UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 195

Sortiert nach

The Childhood Cancer Survivor Study: A National Cancer Institute–Supported Resource for Outcome and Intervention Research

Journal of clinical oncology, 2009-05, Vol.27 (14), p.2308-2318

2009

Volltextzugriff (PDF)

A Single Nucleotide Polymorphism in the MDM2 Promoter Attenuates the p53 Tumor Suppressor Pathway and Accelerates Tumor Formation in Humans

Cell, 2004-11, Vol.119 (5), p.591-602

2004

Volltextzugriff (PDF)

Breast Cancer Risk in Childhood Cancer Survivors Without a History of Chest Radiotherapy: A Report From the Childhood Cancer Survivor Study

Journal of clinical oncology, 2016-03, Vol.34 (9), p.910-918

2016

Volltextzugriff (PDF)

Gain of Function of a p53 Hot Spot Mutation in a Mouse Model of Li-Fraumeni Syndrome

Cell, 2004-12, Vol.119 (6), p.861-872

2004

Volltextzugriff (PDF)

Variants at 6q21 implicate PRDM1 in the etiology of therapy-induced second malignancies after Hodgkin's lymphoma

Nature medicine, 2011-08, Vol.17 (8), p.941-943

2011

Volltextzugriff (PDF)

The cancer predisposition revolution

Science (American Association for the Advancement of Science), 2016-05, Vol.352 (6289), p.1052-1053

2016

Volltextzugriff (PDF)

Characterization of BRCA1 and BRCA2 Mutations in a Large United States Sample

Journal of clinical oncology, 2006-02, Vol.24 (6), p.863-871

2006

Volltextzugriff (PDF)

Cancer Screening Recommendations for Individuals with Li-Fraumeni Syndrome

Clinical cancer research, 2017-06, Vol.23 (11), p.e38-e45

2017

Volltextzugriff (PDF)

Effects of MDM2, MDM4 and TP53 codon 72 polymorphisms on cancer risk in a cohort study of carriers of TP53 germline mutations

PloS one, 2010-05, Vol.5 (5), p.e10813-e10813

2010

Volltextzugriff (PDF)

Characterization of genomic alterations in radiation-associated breast cancer among childhood cancer survivors, using comparative genomic hybridization (CGH) arrays

PloS one, 2015-03, Vol.10 (3), p.e0116078-e0116078

2015

Volltextzugriff (PDF)

Clinically relevant changes in family history of cancer over time

JAMA : the journal of the American Medical Association, 2011-07, Vol.306 (2), p.172

2011

Volltextzugriff (PDF)

Li–Fraumeni Syndrome Disease Model: A Platform to Develop Precision Cancer Therapy Targeting Oncogenic p53

Trends in pharmacological sciences (Regular ed.), 2017-10, Vol.38 (10), p.908-927

2017

Volltextzugriff (PDF)

Activating mutation in MET oncogene in familial colorectal cancer

BMC cancer, 2011-10, Vol.11 (1), p.424-424, Article 424

2011

Volltextzugriff (PDF)

Cancer mortality in relatives of desmoid sarcoma patients

Revista Brasileira de Cancerologia, 2023-07, Vol.36 (1/4), p.45-48

2023

Volltextzugriff (PDF)

Bayesian Semiparametric Estimation of Cancer-Specific Age-at-Onset Penetrance With Application to Li-Fraumeni Syndrome

Journal of the American Statistical Association, 2019-04, Vol.114 (526), p.541-552

2019

Volltextzugriff (PDF)

Assessing BRCA Carrier Probabilities in Extended Families

Journal of clinical oncology, 2006-01, Vol.24 (3), p.354-360

2006

Volltextzugriff (PDF)

Recommendations for Surveillance for Children with Leukemia-Predisposing Conditions

Clinical cancer research, 2017-06, Vol.23 (11), p.e14-e22

2017

Volltextzugriff (PDF)

Lung cancer risk in germline p53 mutation carriers: association between an inherited cancer predisposition, cigarette smoking, and cancer risk

Human genetics, 2003-08, Vol.113 (3), p.238-243

2003

Volltextzugriff (PDF)

Penetrance Estimates Over Time to First and Second Primary Cancer Diagnosis in Families with Li-Fraumeni Syndrome: A Single Institution Perspective

Cancer research (Chicago, Ill.), 2020-01, Vol.80 (2), p.347-353

2020

Volltextzugriff (PDF)

Bayesian estimation of a semiparametric recurrent event model with applications to the penetrance estimation of multiple primary cancers in Li-Fraumeni syndrome

Biostatistics (Oxford, England), 2020-07, Vol.21 (3), p.467-482

2020

Volltextzugriff (PDF)

Increased Risk of Cancer among Siblings of Long-term Childhood Cancer Survivors: A Report from the Childhood Cancer Survivor Study

Cancer epidemiology, biomarkers & prevention, 2005-08, Vol.14 (8), p.1922-1927

2005

Volltextzugriff (PDF)

Early onset HER2‐positive breast cancer is associated with germline TP53 mutations

Cancer, 2012-02, Vol.118 (4), p.908-913

2012

Volltextzugriff (PDF)

Penetrance of Different Cancer Types in Families with Li-Fraumeni Syndrome: A Validation Study Using Multicenter Cohorts

Cancer research (Chicago, Ill.), 2020-01, Vol.80 (2), p.354-360

2020

Volltextzugriff (PDF)

Wt1 ablation and Igf2 upregulation in mice result in Wilms tumors with elevated ERK1/2 phosphorylation

The Journal of clinical investigation, 2011-01, Vol.121 (1), p.174-183

2011

Volltextzugriff (PDF)

Genetic mapping of a third Li-Fraumeni syndrome predisposition locus to human chromosome 1q23

Cancer research (Chicago, Ill.), 2005-01, Vol.65 (2), p.427-431

2005

Volltextzugriff (PDF)

1 – 25 von 195

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(190)
Mit Volltextzugriff
(186)

Publikationsform

Sprache

Englisch
(195)
Japanisch
(30)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

The Childhood Cancer Survivor Study: A National Cancer Institute–Supported Resource for Outcome and Intervention Research

A Single Nucleotide Polymorphism in the MDM2 Promoter Attenuates the p53 Tumor Suppressor Pathway and Accelerates Tumor Formation in Humans

Breast Cancer Risk in Childhood Cancer Survivors Without a History of Chest Radiotherapy: A Report From the Childhood Cancer Survivor Study

Gain of Function of a p53 Hot Spot Mutation in a Mouse Model of Li-Fraumeni Syndrome

Variants at 6q21 implicate PRDM1 in the etiology of therapy-induced second malignancies after Hodgkin's lymphoma

The cancer predisposition revolution

Characterization of BRCA1 and BRCA2 Mutations in a Large United States Sample

Cancer Screening Recommendations for Individuals with Li-Fraumeni Syndrome

Effects of MDM2, MDM4 and TP53 codon 72 polymorphisms on cancer risk in a cohort study of carriers of TP53 germline mutations

Characterization of genomic alterations in radiation-associated breast cancer among childhood cancer survivors, using comparative genomic hybridization (CGH) arrays

Clinically relevant changes in family history of cancer over time

Li–Fraumeni Syndrome Disease Model: A Platform to Develop Precision Cancer Therapy Targeting Oncogenic p53

Activating mutation in MET oncogene in familial colorectal cancer

Cancer mortality in relatives of desmoid sarcoma patients

Bayesian Semiparametric Estimation of Cancer-Specific Age-at-Onset Penetrance With Application to Li-Fraumeni Syndrome

Assessing BRCA Carrier Probabilities in Extended Families

Recommendations for Surveillance for Children with Leukemia-Predisposing Conditions

Lung cancer risk in germline p53 mutation carriers: association between an inherited cancer predisposition, cigarette smoking, and cancer risk

Penetrance Estimates Over Time to First and Second Primary Cancer Diagnosis in Families with Li-Fraumeni Syndrome: A Single Institution Perspective

Bayesian estimation of a semiparametric recurrent event model with applications to the penetrance estimation of multiple primary cancers in Li-Fraumeni syndrome

Increased Risk of Cancer among Siblings of Long-term Childhood Cancer Survivors: A Report from the Childhood Cancer Survivor Study

Early onset HER2‐positive breast cancer is associated with germline TP53 mutations

Penetrance of Different Cancer Types in Families with Li-Fraumeni Syndrome: A Validation Study Using Multicenter Cohorts

Wt1 ablation and Igf2 upregulation in mice result in Wilms tumors with elevated ERK1/2 phosphorylation

Genetic mapping of a third Li-Fraumeni syndrome predisposition locus to human chromosome 1q23

Suchergebnisse filtern